|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165.00 THB | +6.45% |
|
+20.88% | +4.76% |
| 12/01 | Thanachart Securities Downgrades Bumrungrad Hospital to Sell from Buy, Price Target is THB136 | MT |
| 11/11 | Bumrungrad Hospital Public Company Limited, Q3 2025 Earnings Call, Nov 10, 2025 |
| Capitalization | 13TCr 420.55Cr 360.15Cr 334.56Cr 313.07Cr 581.53Cr 38TCr 621.86Cr 3.83TCr 1.52TCr 18TCr 1.58TCr 1.54TCr 67TCr | P/E ratio 2025 * |
18.3x | P/E ratio 2026 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise value | 12TCr 375.1Cr 321.22Cr 298.4Cr 279.24Cr 518.67Cr 34TCr 554.65Cr 3.42TCr 1.35TCr 16TCr 1.41TCr 1.38TCr 60TCr | EV / Sales 2025 * |
4.57x | EV / Sales 2026 * | 4.33x |
| Free-Float |
85.99% | Yield 2025 * |
3.07% | Yield 2026 * | 3.2% |
Last Transcript: Bumrungrad Hospital
| 1 day | +6.45% | ||
| 1 week | +20.88% | ||
| Current month | +4.76% | ||
| 1 month | +1.54% | ||
| 3 months | -7.04% | ||
| 6 months | +13.79% | ||
| Current year | +4.76% |
| 1 week | 140 |  | 165 |
| 1 month | 136 | | 165.5 |
| Current year | 136 | | 165 |
| 1 year | 130 | | 198.5 |
| 3 years | 130 | | 284 |
| 5 years | 116.5 | | 284 |
| 10 years | 90.5 | | 284 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 31/01/2019 | |
Oraphan Buamuang
DFI | Director of Finance/CFO | 52 | 19/08/2019 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 11/10/2017 | |
Chong Toh
BRD | Director/Board Member | 57 | 08/04/2001 |
Prin Chirathivat
BRD | Director/Board Member | 62 | 27/02/2012 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.45% | +20.88% | -13.39% | -21.05% | 396.92Cr | |
| +0.23% | -2.90% | +49.92% | +78.06% | 11TCr | |
| +1.75% | +1.00% | +54.87% | -6.33% | 10TCr | |
| +1.10% | -7.03% | +30.95% | +68.16% | 3.11TCr | |
| +1.47% | +0.54% | -9.00% | +15.45% | 2.42TCr | |
| -0.80% | +5.97% | +12.82% | +5.30% | 2.25TCr | |
| -2.28% | +2.61% | +22.12% | +26.97% | 2.1TCr | |
| -1.26% | -4.20% | +45.83% | +270.26% | 1.7TCr | |
| +2.27% | +2.06% | +52.04% | +45.41% | 1.65TCr | |
| +1.91% | +0.93% | +10.22% | +36.27% | 1.25TCr | |
| Average | +0.88% | +1.79% | +25.64% | +51.85% | 3.56TCr | |
| Weighted average by Cap. | +0.18% | -0.90% | +39.50% | +46.35% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.56TCr 82Cr 70Cr 65Cr 61Cr 113.56Cr 7.51TCr 121.43Cr 748.54Cr 296.25Cr 3.57TCr 307.95Cr 301.62Cr 13TCr | 2.69TCr 86Cr 74Cr 69Cr 64Cr 119.15Cr 7.88TCr 127.42Cr 785.44Cr 310.85Cr 3.74TCr 323.13Cr 316.49Cr 14TCr |
| Net income | 748.45Cr 24Cr 21Cr 19Cr 18Cr 33Cr 2.2TCr 35Cr 218.73Cr 87Cr 1.04TCr 90Cr 88Cr 3.85TCr | 785.73Cr 25Cr 22Cr 20Cr 19Cr 35Cr 2.31TCr 37Cr 229.62Cr 91Cr 1.09TCr 94Cr 93Cr 4.04TCr |
| Net Debt | -1.42TCr -45Cr -39Cr -36Cr -34Cr -63Cr -4.16TCr -67Cr -414.31Cr -163.97Cr -1.97TCr -170.45Cr -166.94Cr -7.29TCr | -1.49TCr -48Cr -41Cr -38Cr -36Cr -66Cr -4.37TCr -71Cr -435.1Cr -172.2Cr -2.07TCr -179Cr -175.32Cr -7.65TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | 165.00 ฿ | +6.45% | 1,20,37,920 |
| 20/26/20 | 155.00 ฿ | +3.33% | 1,12,47,940 |
| 19/26/19 | 150.00 ฿ | +4.53% | 79,74,698 |
| 16/26/16 | 143.50 ฿ | +0.35% | 62,37,378 |
| 15/26/15 | 143.00 ฿ | +2.14% | 67,00,898 |
End-of-day quote Thailand S.E., January 21, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition